Gro Gausdal

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

AXL-TBK1 driven AKT3 activation promotes metastasis.

AXL-TBK1 driven AKT3 activation promotes metastasis.

Journal: Science signaling

Published: December 17, 2024

Targeting AXL cellular networks in kidney fibrosis.

Targeting AXL cellular networks in kidney fibrosis.

Journal: Frontiers in immunology

Published: June 10, 2024

AXL Kinase Inhibition Promotes Cytosolic DNA Sensor cGAS Activity and Sensitizes Poorly Immunogenic Tumors to Chemo-Immunotherapy.

AXL Kinase Inhibition Promotes Cytosolic DNA Sensor cGAS Activity and Sensitizes Poorly Immunogenic Tumors to Chemo-Immunotherapy.

Journal: Molecular cancer therapeutics

Published: June 07, 2024

Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.

Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.

Journal: Frontiers in immunology

Published: March 13, 2024

In vivo turnover and biodistribution of soluble AXL: implications for biomarker development.

In vivo turnover and biodistribution of soluble AXL: implications for biomarker development.

Journal: Scientific reports

Published: March 13, 2024

Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.

Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.

Journal: Cancer research

Published: August 16, 2022

AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.

AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.

Journal: Physiological reports

Published: October 29, 2021

Phosphatidylserine receptors enhance SARS-CoV-2 infection.

Phosphatidylserine receptors enhance SARS-CoV-2 infection.

Journal: PLoS pathogens

Published: June 25, 2021

Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19.

Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19.

Journal: bioRxiv : the preprint server for biology

Published: June 23, 2021

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells.

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells.

Journal: Cell reports. Medicine

Published: May 10, 2021

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 16, 2021

Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model.

Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model.

Journal: Journal of cellular and molecular medicine

Published: February 25, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026